Jupiter Asset Management Ltd. boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 100.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,705 shares of the company’s stock after acquiring an additional 5,869 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in HealthEquity were worth $1,072,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Torren Management LLC acquired a new stake in HealthEquity during the 4th quarter worth about $40,000. AlphaQuest LLC boosted its position in HealthEquity by 52.2% during the 3rd quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after acquiring an additional 214 shares during the period. Larson Financial Group LLC boosted its position in HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock worth $60,000 after acquiring an additional 123 shares during the period. Allworth Financial LP boosted its position in HealthEquity by 88.3% during the 4th quarter. Allworth Financial LP now owns 706 shares of the company’s stock worth $65,000 after acquiring an additional 331 shares during the period. Finally, IFP Advisors Inc boosted its position in HealthEquity by 1,602.3% during the 3rd quarter. IFP Advisors Inc now owns 749 shares of the company’s stock worth $75,000 after acquiring an additional 705 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
HQY has been the subject of a number of recent research reports. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. Barrington Research reaffirmed an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research note on Friday, May 22nd. JPMorgan Chase & Co. cut their price target on HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research note on Wednesday, March 18th. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Finally, Raymond James Financial set a $100.00 price target on HealthEquity in a research note on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $112.36.
Trending Headlines about HealthEquity
Here are the key news stories impacting HealthEquity this week:
- Positive Sentiment: HealthEquity beat Q1 FY27 expectations, reporting $1.24 EPS on $354.6 million in revenue, with revenue up 7.2% year over year and net income up 29%; the company also raised its full-year outlook. HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
- Positive Sentiment: The company expanded its share repurchase authorization by $1 billion, which can support per-share earnings and signals confidence in future cash generation. HealthEquity outlines fiscal 2027 revenue of $1.41B-$1.42B while expanding share repurchase authorization by $1B
- Positive Sentiment: Royal Bank of Canada raised its price target on HealthEquity to $108 from $100 and reiterated an outperform rating, implying further upside from current levels. Benzinga
- Neutral Sentiment: Earnings call coverage and transcript articles highlighted management commentary, but did not add materially new investor information beyond the reported results and guidance. HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript
- Neutral Sentiment: Short-interest data showed no meaningful change to the stock’s trading backdrop. HealthEquity (NASDAQ:HQY) – Get Free Report
HealthEquity Stock Performance
HQY opened at $87.99 on Friday. The firm has a market capitalization of $7.38 billion, a P/E ratio of 32.96, a price-to-earnings-growth ratio of 1.60 and a beta of 0.19. The stock’s 50 day moving average price is $83.44 and its two-hundred day moving average price is $86.77. The company has a quick ratio of 3.27, a current ratio of 3.27 and a debt-to-equity ratio of 0.45. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65.
HealthEquity (NASDAQ:HQY – Get Free Report) last released its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The firm had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.61% and a net margin of 17.25%.The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts forecast that HealthEquity, Inc. will post 3.84 earnings per share for the current year.
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Stories
- Five stocks we like better than HealthEquity
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
